Gates recruits Novartis development chief, paper says

Word in the Swiss media is that the Gates Foundation is trying to woo away Novartis' ($NVS) Trevor Mundel, aiming to install him as executive director of global health. Mundel has headed up Novartis' global development efforts since 2008. Report

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.